General Information
Revision date
2009-07-06
Product name
PR-1436-G Sprayable, Part A
1.2.2. Uses advised against
None
supplier name
PRC-DeSoto International
Manufacturer Name
PRC-DeSoto International, Inc Information
Emergency telephone
(800) 228-5635
Icons in SDS
Company Information
company name
PRC-DeSoto International
Section 2
Hazardous Ingredients
INGREDIENT CAS NUMBER Wt % Dimethylacetamide 000127-19-5 10 - 30 Calcium dichromate 014307-33-6 10 - 30 Sodium Dichromate Dihydrate 010588-01-9 7 - 1 3 EXPOSURE LIMITS (ppm) ACGIH TLVs OSHA PELs INGREDIENT CAS NUMBER TWA STEL TWA STEL Dimethylacetamide 00012 7-19-5 10 N/E 10 N/E Calcium dichromate 014307-33-6 0.05 mg/M3N/E Sodium Dichromate Dihydrate 010588-01-9 Page Number Cont 0.05 mg/m3N/E 0.1 mg/m3 N/E S Footnotes (M) Maximum Exposure Limit (S) Occupational Exposure Standard (R) Supplier's Recommended Limit N/Av = Not Available = X N/Ap = Not Applicable N/E = Not Established
Health hazards
DATA Permissible Exposure Limits for Product: Not established for product. See Section II.
Principle Routes of Exposure
AND EFFECTS OF OVER-EXPOSURE EYE CONTACT : Irritation. May cause burning, tearing and reddening. SKIN CONTACT : Prolonged or repeated contact may result in irritation, defatting or dermatitis. INHALATION: May cause irritation to nose and respiratory tract. Prolonged over-exposure may result in central nervous system depression characterized by headache, dizziness, staggering gait, confusion or unconsciousness. INGESTION : Can irritate the stomach and intestines. Can cause nausea, vomiting and diarrhea. Large amounts can cause liver and kidney damage.
Other Health Effects
This material contains no ingredient known or suspected to be a carcinogen, teratogen, mutagen or reproductive toxin unless indicated below. No synergistic materials known unless indicated below. Dimethylacetamide is readily absorbed through the skin. Laboratory Page Number 2 Continued tests have shown that dermal application of DMAC to pregnant rats produced fetal abnormalities. Hexavalent chromium compounds are listed by lARC and NTP as being confirmed human carcinogens. Prolonged exposure to hexavalent chromium compounds over the TWA may cause painless penetrating ulcers of the skin. Prolonged exposure to hexavalent chromium compounds over the TWA may cause penetrating ulcers of the mucous membranes or the nose and perforation of the cartilaginous nasal septum.
